James Grosfeld has given $11.5 million to Michigan Medicine for research related to dry age-related macular degeneration (AMD).

The period between laboratory success and commercialization is often called "the valley of death." At Michigan Medicine, many organizations exist to help get physicians' and researchers' brilliant ideas across the chasm.

Researchers will work to find alternative treatments for non-small cell lung cancers that have become resistant to standard treatment

Paul and Carolyn Lichter make generous plans for the future.

Generous donations support COVID-19 philanthropy

U-M researchers are in high gear

Supporting research to advance treatment and prevention of the world's second-leading cause of blindness